Please login to the form below

Not currently logged in
Email:
Password:

MHRA upholds Lundbeck complaint

The Medicines and Healthcare products Regulatory Agency has upheld a complaint against Lundbeck UK. 

The Medicines and Healthcare products Regulatory Agency (MHRA) has upheld a complaint against Lundbeck UK. 

A complaint was made to the MHRA that a website containing information on the product Serdolect, was linked to from the Lundbeck UK company website although it is not currently marketed in the UK and allowed open-access to promotional information for healthcare professionals.

Lundbeck stated that they did not intend to promote to a UK audience and removed the unintended link from the UK website. 
 
 

22nd January 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics